6-K
File 001-15170
GSK BOARD CHANGE
- Filing date
- 29 Jul 2022
- Reporting date
- 29 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,801 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 951-975 of 1,000 matching filings.
Per page
25
Current page
39
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 28 Jul 2022
- Reporting date
- 28 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC 13D
SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
- Filing date
- 27 Jul 2022
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
2ND QUARTER RESULTS
- Filing date
- 27 Jul 2022
- Reporting date
- 27 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HOLDING(S) IN COMPANY
- Filing date
- 22 Jul 2022
- Reporting date
- 22 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BOARD AND COMMITTEE CHANGES
- Filing date
- 22 Jul 2022
- Reporting date
- 22 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
COMPLETION OF GSK SHARE CONSOLIDATION
- Filing date
- 18 Jul 2022
- Reporting date
- 18 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
HALEON DEMERGER COMPLETION AND SHARE CONSOLIDATION
- Filing date
- 18 Jul 2022
- Reporting date
- 18 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 12 Jul 2022
- Reporting date
- 12 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 08 Jul 2022
- Reporting date
- 08 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
RESULT OF GENERAL MEETING
- Filing date
- 06 Jul 2022
- Reporting date
- 06 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 06 Jul 2022
- Reporting date
- 06 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK DISCLOSE DISCONTINUED OPERATIONS FROM Q2 2022
- Filing date
- 05 Jul 2022
- Reporting date
- 05 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 05 Jul 2022
- Reporting date
- 05 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 05 Jul 2022
- Reporting date
- 05 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 01 Jul 2022
- Reporting date
- 01 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK COMPLETES ACQUISITION OF SIERRA ONCOLOGY
- Filing date
- 01 Jul 2022
- Reporting date
- 01 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 28 Jun 2022
- Reporting date
- 28 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
11-K
File 001-15170
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
- Filing date
- 28 Jun 2022
- Reporting date
- 31 Dec 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
11-K
File 001-15170
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
- Filing date
- 28 Jun 2022
- Reporting date
- 31 Dec 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK FILES SHINGRIX 18+ AT RISK INDICATION IN JAPAN
- Filing date
- 28 Jun 2022
- Reporting date
- 28 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing